Spectrum Solutions Launches New Saliva Diagnostic Testing Solution

Saliva diagnostic biotech leader Spectrum Solutions’® newest product is the SimplyPERIO™ saliva diagnostic testing innovation, an economical solution that uses a proprietary molecular technology to test for and measure periodontal bacteria, caries, fungal and viral targets.

As advances in science continue to focus on the mouth-body connection and its direct link to systemic disease, the new SimplyPERIO Saliva Test Powered by SimplyTest® looks to fill a testing void by delivering more intelligent health measures with real clinical relevance using 16 oral targets from a single patient sample.

A patented blue buffer solution located inside the collection device’s cap stabilizes saliva samples at room temperature eliminating any special post-collection storage or shipping requirements. The diagnostic testing solution is designed to be quick and easy for dental practices to perform and to get processed.

Periodontal disease—often undiagnosed and untreated—has some of the highest negative impacts on many bodily systems and functions.In addition, it decreases a person’s ability to fight infection and inflammation.

Understanding treatment success is often influenced by host immunity and host response, this unique, highly sensitive and highly specific saliva test offers clinicians an opportunity to elevate patient care with the most complete oral health picture, states SpectrumSolutions.

“We are using science to make saliva diagnostics simple for both patients and providers. SimplyPERIO testing is not only pain-free it takes less than 30 seconds for a patient to collect their own sample,” David Vigerust, PhD, chief science officer at Spectrum Solutions, says in a press release. “In addition, our CAP accredited laboratory delivers providers the independent, third party results necessary for intelligent, data-supported patient conversations about stopping and even reversing their disease and systemic risks.”

Gingivitis, periodontitis and peri-implantitis are all forms of gum disease, and research indicates that in the U.S., about 80% of individuals over 35 have a form of gum disease. Spectrum Solutions says these numbers demonstrate that for the vast majority, there maybe dangerous and damaging periodontal disease pathogens hiding that can't be identified with a perio-probe or visual exam during a patient’s regular semi-annual cleanings.

Gone undetected and untreated, these harmful oral bacteria and toxins are allowed to sit and accumulate inside the mouth and can lead to a variety of health issues. From inside the mouth these microorganisms move freely to and through the bloodstream with far reaching and catastrophic effects on the heart, arteries, central nervous system and more, the manufacturer warns.

The SimplyPERIO patented blue buffer solution located inside the collection device’s cap stabilizes saliva samples to ensure accurate samples are delivered to the lab. Users can easily deposit 1 sample at a time, which supports at-home patient testing for follow-up and treatment monitoring, or practices can gather an entire day’s worth of in-office collections into the USPS postage-paid return box for mailing samples back to the lab for processing. Results are available in a secure HIPAA compliant portal 48 hours after arriving at the lab.

The pain-free testing takes less than 30 seconds and is designed to deliver clinically relevant support using independent, third-party results for intelligent patient conversations on stopping and even reversing disease risks.

SimplyTest and Spectrum Solutions are registered trademarks of SpectrumSolution, LLC, headquartered in Salt Lake City, Utah. The company’s single-source, end-to-end capabilities include a CAP accredited molecular diagnostic laboratory, onsite compounding pharmacy, product development, manufacturing and fulfillment.

To watch a video on SimplyPERIO filmed by Dental Products Report at the 2024 Chicago Dental Society Midwinter Meeting, click here.